Showing 1 - 4 results of 4 for search 'Maria L Naylor', query time: 0.02s
Refine Results
-
1
Peginterferon β-1a every 2 weeks increased achievement of no evidence of disease activity over 4 years in the ADVANCE and ATTAIN studies in patients with relapsing–remitting multip... by Douglas L. Arnold, Shulian Shang, Qunming Dong, Matthias Meergans, Maria L. Naylor
Published 2018-08-01
Article -
2
Matching comparisons of therapeutic efficacy suggest better clinical outcomes for patients treated with peginterferon beta-1a than with glatiramer acetate by Thomas F. Scott, Ray Su, Kuangnan Xiong, Arman Altincatal, Carmen Castrillo-Viguera, Maria L. Naylor
Published 2021-01-01
Article -
3
1111 Increasing access and quality of care for individuals from underrepresented communities living with lupus: insights from qualitative interviews with patients and physicians by Saira Z Sheikh, Maria L Naylor, Lasair O’Callaghan, Lina Sladkeviciute, Janine Gaiha-Rohrbach, Cherie Butts
Published 2021-11-01Article -
4
Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN by Scott D. Newsome, Thomas F. Scott, Douglas L. Arnold, Gereon Nelles, Serena Hung, Yue Cui, Shulian Shang, Maria L. Naylor, Marcelo Kremenchutzky
Published 2018-08-01
Article